Pediatric Unit, Le Havre Hospital, Le Havre Cedex, France.
INSERM U1073, UNIROUEN, Normandie University, Rouen, France.
Eur Eat Disord Rev. 2024 May;32(3):589-605. doi: 10.1002/erv.3063. Epub 2024 Feb 2.
The DSM-5 classification introduced new Feeding and Eating Disorders (FED) diagnostic categories, notably Avoidant and Restrictive Food Intake Disorder (ARFID), which, like other FED, can present psychiatric and gastrointestinal symptoms. However, paediatric clinical research that focuses on children below the age of 12 years remains scarce. The aim of this study was first to investigate the clinical features of FED in a cohort of children, second to compare them according to their recruitment (gastroenterology or psychiatry unit).
This non-interventional retrospective cohort study analysed 191 patients in a French paediatric tertiary care centre (gastroenterology n = 100, psychiatry n = 91). The main outcome variables were clinical data (type of FED, BMI, nutritional support, chronic diseases, psychiatric comorbidities, sensory, sleep, language disorders, gastrointestinal complaints, adverse life events, family history). The outcome was defined by a Clinical Global Impression of Change-score.
FED diagnoses were ARFID (n = 100), Unspecified FED (UFED, n = 57), anorexia nervosa (AN, n = 33) and one pica/rumination. Mean follow-up was 3.28 years (SD 1.91). ARFID was associated with selective and sensory disorders (p < 0.001); they had more anxiety disorders than patients with UFED (p < 0.001). Patients with UFED had more chewing difficulties, language disorder (p < 0.001), and more FED related to chronic disease (p < 0.05) than patients with ARFID and AN. Patients with AN were female, underweight, referred exclusively to the psychiatrist, and had more depression than patients with ARFID and UFED (p < 0.001). The gastroenterology cohort included more UFED, while the psychiatry cohort included more psychiatric comorbidities (p < 0.001). A worse clinical outcome was associated with ARFID, a younger age at onset (p < 0.001), selective/sensory disorders and nutritional support (p < 0.05).
ARFID and UFED children were diagnosed either by gastroenterologists or psychiatrists. Due to frequently associated somatic and psychiatric comorbidities, children with FED should benefit from a multidisciplinary assessment and care.
DSM-5 分类引入了新的进食障碍(FED)诊断类别,特别是回避性和限制性摄食障碍(ARFID),与其他 FED 一样,它可能出现精神和胃肠道症状。然而,针对 12 岁以下儿童的儿科临床研究仍然很少。本研究的目的首先是在一个儿童队列中调查 FED 的临床特征,其次是根据他们的招募情况(胃肠病学或精神病学病房)进行比较。
这项非干预性回顾性队列研究分析了法国一家儿科三级保健中心的 191 名患者(胃肠病学 n=100,精神病学 n=91)。主要的结局变量是临床数据(FED 类型、BMI、营养支持、慢性疾病、精神共病、感觉、睡眠、语言障碍、胃肠道投诉、不良生活事件、家族史)。结局由临床总体印象变化评分定义。
FED 诊断为 ARFID(n=100)、未特指的 FED(UFED,n=57)、神经性厌食症(AN,n=33)和 1 例异食癖/反刍。平均随访时间为 3.28 年(标准差 1.91)。ARFID 与选择性和感觉障碍有关(p<0.001);与 UFED 患者相比,他们有更多的焦虑障碍(p<0.001)。UFED 患者更难咀嚼、语言障碍(p<0.001),与慢性疾病相关的 FED 也更多(p<0.05),而 ARFID 和 AN 患者则较少。AN 患者为女性,体重不足,仅由精神病医生转介,抑郁程度高于 ARFID 和 UFED 患者(p<0.001)。胃肠病学组包括更多的 UFED,而精神病学组包括更多的精神共病(p<0.001)。较差的临床结局与 ARFID、发病年龄较小(p<0.001)、选择性/感觉障碍和营养支持有关(p<0.05)。
ARFID 和 UFED 儿童由胃肠病学家或精神病学家诊断。由于经常伴有躯体和精神共病,FED 患儿应受益于多学科评估和护理。